Literature DB >> 7044291

Antibacterial properties of alafosfalin combined with cephalexin.

F R Atherton, M J Hall, C H Hassall, S W Holmes, R W Lambert, W J Lloyd, L J Nisbet, P S Ringrose, D Westmacott.   

Abstract

The phosphonopeptide alafosfalin (L-alanyl-L-1-aminoethylphosphonic acid) exhibited synergy in vitro and in animal studies against a range of bacterial genera when combined with cephalexin. Alafosfalin also showed synergy with mecillinam and, to a much lesser extent, with ampicillin. Synergy with cephalexin was more pronounced when the bacteria were relatively insensitive to the beta-lactam component. The action of this combination involved both an inhibitory and a bacteriolytic mechanism which was abolished by concurrent treatment with the aminopeptidase inhibitor, bestatin. Regrowth of subpopulation resistant to either component was markedly reduced by the combination. The potential of alafosfalin combined with cephalexin for use in therapy is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7044291      PMCID: PMC181725          DOI: 10.1128/AAC.20.4.470

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  THE ENZYMATIC SYNTHESIS OF D-ALANYL-D-ALANINE. 3. ON THE INHIBITION OF D-ALANYL-D-ALANINE SYNTHETASE BY THE ANTIBIOTIC D-CYCLOSERINE.

Authors:  F C NEUHAUS; J L LYNCH
Journal:  Biochemistry       Date:  1964-04       Impact factor: 3.162

2.  Use of antibiotics. Infection in the compromised host.

Authors:  A P Gillett; R Wise; A M Geddes
Journal:  Br Med J       Date:  1978-07-29

3.  Phosphonomycin. 3. Evaluation in vitro.

Authors:  D Hendlin; B M Frost; E Thiele; H Kropp; M E Valiant; B Pelak; B Weissberger; C Cornin; A K Miller
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

4.  Phosphonopeptides as antibacterial agents: rationale, chemistry, and structure-activity relationships.

Authors:  F R Atherton; M J Hall; C H Hassall; R W Lambert; P S Ringrose
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

5.  Phosphonopeptides, a new class of synthetic antibacterial agents.

Authors:  J G Allen; F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; L J Nisbet; P S Ringrose
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

Review 6.  Mode of action of beta-lactam antibiotics.

Authors:  D J Tipper
Journal:  Rev Infect Dis       Date:  1979 Jan-Feb

7.  Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin.

Authors:  F R Atherton; M J Hall; C H Hassall; R W Lambert; W J Lloyd; P S Ringrose
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

8.  Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides.

Authors:  J G Allen; F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; L J Nisbet; P S Ringrose
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

9.  Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships.

Authors:  F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; W J Lloyd; P S Ringrose
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

10.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

View more
  6 in total

1.  Loss of Pseudomonas aeruginosa PhpA aminopeptidase activity results in increased algD transcription.

Authors:  S C Woolwine; A B Sprinkle; D J Wozniak
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

2.  Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.

Authors:  P Angehrn; M J Hall; W J Lloyd; D Westmacott
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

3.  Phosphonopeptides as substrates for peptide transport systems and peptidases of Escherichia coli.

Authors:  F R Atherton; M J Hall; C H Hassall; R W Lambert; W J Lloyd; A V Lord; P S Ringrose; D Westmacott
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

4.  In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.

Authors:  M Arisawa; J Ohshima; E Ohsawa; H B Maruyama
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

5.  Antibacterial activity and mechanism of action of phosphonopeptides based on aminomethylphosphonic acid.

Authors:  F R Atherton; M J Hall; C H Hassall; R W Lambert; W J Lloyd; P S Ringrose; D Westmacott
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

6.  Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance.

Authors:  Emma C L Marrs; Linda Varadi; Alexandre F Bedernjak; Kathryn M Day; Mark Gray; Amanda L Jones; Stephen P Cummings; Rosaleen J Anderson; John D Perry
Journal:  Molecules       Date:  2020-03-23       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.